{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:05:53Z","timestamp":1789848353852,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1124\/jpet.105.100362","type":"journal-article","created":{"date-parts":[[2006,2,25]],"date-time":"2006-02-25T01:45:47Z","timestamp":1140831947000},"page":"1044-1053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Inhibition of p38 Mitogen-Activated Protein Kinase Prevents Inflammatory Bone Destruction"],"prefix":"10.1016","volume":"317","author":[{"given":"Gabriel","family":"Mbalaviele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"De Ciechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Settle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Mnich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Thiede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Abu-Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Portanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Monahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.105.100362_bib1","doi-asserted-by":"crossref","unstructured":"Badger AM, Griswold DE, Kapadia R, Blake S, Swift BA, Hoffman SJ, Stroup GB, Webb E, Rieman DJ, Gowen M, et al. (2000) Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. Arthritis Rheum 43: 175\u2013183.","DOI":"10.1002\/1529-0131(200001)43:1<175::AID-ANR22>3.0.CO;2-S"},{"key":"10.1124\/jpet.105.100362_bib2","doi-asserted-by":"crossref","unstructured":"Bennett BL, Sasaki DT, Murray BW, O\u2019Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, et al. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98: 13681\u201313686.","DOI":"10.1073\/pnas.251194298"},{"key":"10.1124\/jpet.105.100362_bib3","doi-asserted-by":"crossref","unstructured":"Brahn E (1991) Animal models of rheumatoid arthritis: clues to etiology and treatment. Clin Orthop 265: 42\u201353.","DOI":"10.1097\/00003086-199104000-00006"},{"key":"10.1124\/jpet.105.100362_bib4","doi-asserted-by":"crossref","unstructured":"Choy EH and Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344: 907\u2013916.","DOI":"10.1056\/NEJM200103223441207"},{"key":"10.1124\/jpet.105.100362_bib5","doi-asserted-by":"crossref","unstructured":"Collin-Osdoby P, Rothe L, Anderson F, Nelson M, Maloney W, and Osdoby P (2001) Receptor activator of NF-\u03baB and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines and role in human osteoclastogenesis. J Biol Chem 276: 20659\u201320672.","DOI":"10.1074\/jbc.M010153200"},{"key":"10.1124\/jpet.105.100362_bib6","doi-asserted-by":"crossref","unstructured":"Darnay BG, Singh S, and Aggarwal BB (1997) The p80 TNF receptor-associated kinase (p80TRAK) associates with residues 354\u2013397 of the p80 cytoplasmic domain: similarity to casein kinase. FEBS Lett 406: 101\u2013105.","DOI":"10.1016\/S0014-5793(97)00251-2"},{"key":"10.1124\/jpet.105.100362_bib7","doi-asserted-by":"crossref","unstructured":"David JP, Sabapathy K, Hoffmann O, Idarraga MH, and Wagner EF (2002) c-Jun phosphorylation by JNK1 but not JNK2 is necessary for efficient osteoclastogenesis in response to TRANCE stimulation. J Cell Sci 115: 4317\u20134325.","DOI":"10.1242\/jcs.00082"},{"key":"10.1124\/jpet.105.100362_bib8","doi-asserted-by":"crossref","unstructured":"Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, Henriksen K, Lenhard T, Foged NT, Werb Z, et al. (2000) Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151: 879\u2013889.","DOI":"10.1083\/jcb.151.4.879"},{"key":"10.1124\/jpet.105.100362_bib9","doi-asserted-by":"crossref","unstructured":"Feng X (2005) Regulatory roles and molecular signaling of TNF family members in osteoclasts. Gene (Amst) 350: 1\u201313.","DOI":"10.1016\/j.gene.2005.01.014"},{"key":"10.1124\/jpet.105.100362_bib10","doi-asserted-by":"crossref","unstructured":"Garg A and Aggarwal BB (2002) Nuclear transcription factor-\u03baB as a target for cancer drug development. Leukemia 16: 1053\u20131068.","DOI":"10.1038\/sj.leu.2402482"},{"key":"10.1124\/jpet.105.100362_bib11","doi-asserted-by":"crossref","unstructured":"Goldring SR and Gravallese EM (2000) Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res 2: 33\u201337.","DOI":"10.1186\/ar67"},{"key":"10.1124\/jpet.105.100362_bib12","doi-asserted-by":"crossref","unstructured":"Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, and Wagner EF (1994) c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science (Wash DC) 266: 443\u2013448.","DOI":"10.1126\/science.7939685"},{"key":"10.1124\/jpet.105.100362_bib13","doi-asserted-by":"crossref","unstructured":"Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L, Manning AM, and Firestein GS (2001) c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Investig 108: 73\u201381.","DOI":"10.1172\/JCI12466"},{"key":"10.1124\/jpet.105.100362_bib14","doi-asserted-by":"crossref","unstructured":"Han Z, Boyle DL, Manning AM, and Firestein GS (1998) AP-1 and NF-\u03baB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity 28: 197\u2013208.","DOI":"10.3109\/08916939808995367"},{"key":"10.1124\/jpet.105.100362_bib15","doi-asserted-by":"crossref","unstructured":"Hom JT, Gliszczynski VL, Cole HW, and Bendele AM (1991) Interleukin 1 mediated acceleration of type II collagen-induced arthritis: effects of anti-inflammatory or anti-arthritic drugs. Agents Actions 33: 300\u2013309.","DOI":"10.1007\/BF01986577"},{"key":"10.1124\/jpet.105.100362_bib16","doi-asserted-by":"crossref","unstructured":"Komine M, Kukita A, Kukita T, Ogata Y, Hotokebuchi T, and Kohashi O (2001) Tumor necrosis factor-\u03b1 cooperates with receptor activator of nuclear factor \u03baB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture. Bone (NY) 28: 474\u2013483.","DOI":"10.1016\/S8756-3282(01)00420-3"},{"key":"10.1124\/jpet.105.100362_bib17","doi-asserted-by":"crossref","unstructured":"Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, et al. (1999a) Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature (Lond) 402: 304\u2013309.","DOI":"10.1038\/46303"},{"key":"10.1124\/jpet.105.100362_bib18","doi-asserted-by":"crossref","unstructured":"Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveirados-Santos AJ, Van G, Itie A, et al. (1999b) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature (Lond) 397: 315\u2013323.","DOI":"10.1038\/16852"},{"key":"10.1124\/jpet.105.100362_bib19","doi-asserted-by":"crossref","unstructured":"Kumar S, Votta BJ, Rieman DJ, Badger AM, Gowen M, and Lee JC (2001) IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase. J Cell Physiol 187: 294\u2013303.","DOI":"10.1002\/jcp.1082"},{"key":"10.1124\/jpet.105.100362_bib20","doi-asserted-by":"crossref","unstructured":"Kyriakis JM and Avruch J (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81: 807\u2013869.","DOI":"10.1152\/physrev.2001.81.2.807"},{"key":"10.1124\/jpet.105.100362_bib21","doi-asserted-by":"crossref","unstructured":"Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, and Teitelbaum SL (2000) TNF-\u03b1 induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Investig 106: 1481\u20131488.","DOI":"10.1172\/JCI11176"},{"key":"10.1124\/jpet.105.100362_bib22","doi-asserted-by":"crossref","unstructured":"Lee SE, Woo KM, Kim SY, Kim HM, Kwack K, Lee ZH, and Kim HH (2002) The phosphatidylinositol 3-kinase, p38 and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone (NY) 30: 71\u201377.","DOI":"10.1016\/S8756-3282(01)00657-3"},{"key":"10.1124\/jpet.105.100362_bib23","doi-asserted-by":"crossref","unstructured":"Li X, Udagawa N, Itoh K, Suda K, Murase Y, Nishihara T, Suda T, and Takahashi N (2002) p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology 143: 3105\u20133113.","DOI":"10.1210\/endo.143.8.8954"},{"key":"10.1124\/jpet.105.100362_bib24","doi-asserted-by":"crossref","unstructured":"Mansky KC, Marfatia K, Purdom GH, Luchin A, Hume DA and Ostrowski MC (2002a) The microphthalmia transcription factor (MITF) contains two N-terminal domains required for transactivation of osteoclast target promoters and rescue of mi mutant osteoclasts. J Leukoc Biol 71: 295\u2013303.","DOI":"10.1189\/jlb.71.2.295"},{"key":"10.1124\/jpet.105.100362_bib25","doi-asserted-by":"crossref","unstructured":"Mansky KC, Sankar U, Han J, and Ostrowski MC (2002b) Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-\u03baB ligand signaling. J Biol Chem 277: 11077\u201311083.","DOI":"10.1074\/jbc.M111696200"},{"key":"10.1124\/jpet.105.100362_bib26","doi-asserted-by":"crossref","unstructured":"Matsumoto M, Kogawa M, Wada S, Takayanagi H, Tsujimoto M, Katayama S, Hisatake K, and Nogi Y (2004) Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis. J Biol Chem 279: 45969\u201345979.","DOI":"10.1074\/jbc.M408795200"},{"key":"10.1124\/jpet.105.100362_bib27","doi-asserted-by":"crossref","unstructured":"Matsumoto M, Sudo T, Saito T, Osada H, and Tsujimoto M (2000) Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-\u03baB ligand (RANKL). J Biol Chem 275: 31155\u201331161.","DOI":"10.1074\/jbc.M001229200"},{"key":"10.1124\/jpet.105.100362_bib28","doi-asserted-by":"crossref","unstructured":"Mbalaviele G, Chen H, Boyce BF, Mundy GR, and Yoneda T (1995) The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow. J Clin Investig 95: 2757\u20132765.","DOI":"10.1172\/JCI117979"},{"key":"10.1124\/jpet.105.100362_bib29","doi-asserted-by":"crossref","unstructured":"Merrell M, Suarez-Cuervo C, Harris KW, V\u00e4\u00e4n\u00e4nen HK, and Selander KS (2003) Bisphosphonate induced growth inhibition of breast cancer cells is augmented by p38 inhibition. Breast Cancer Res Treat 81: 231\u2013241.","DOI":"10.1023\/A:1026126430905"},{"key":"10.1124\/jpet.105.100362_bib30","doi-asserted-by":"crossref","unstructured":"Min H, Morony S, Sarosi I, Dunstan CR, Capparelli C, Scully S, Van G, Kaufman S, Kostenuik PJ, Lacey DL, et al. (2000) Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med 192: 463\u2013474.","DOI":"10.1084\/jem.192.4.463"},{"key":"10.1124\/jpet.105.100362_bib31","doi-asserted-by":"crossref","unstructured":"Miyazaki T, Katagiri H, Kanegae Y, Takayanagi H, Sawada Y, Yamamoto A, Pando MP, Asano T, Verma IM, Oda H, et al. (2000) Reciprocal role of ERK and NF-\u03baB pathways in survival and activation of osteoclasts. J Cell Biol 148: 333\u2013342.","DOI":"10.1083\/jcb.148.2.333"},{"key":"10.1124\/jpet.105.100362_bib32","unstructured":"Mundy GR, Boyce BF, Yoneda T, Bonewald LF, and Roodman GD (1995) Cytokines and bone remodeling, in Osteoporosis (Marcus R, Feldman D, and Kelsey J eds) pp 302\u2013313, Academic Press, San Diego, CA."},{"key":"10.1124\/jpet.105.100362_bib33","doi-asserted-by":"crossref","unstructured":"Pacifici R (1996) Estrogen, cytokines and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11: 1043\u20131051.","DOI":"10.1002\/jbmr.5650110802"},{"key":"10.1124\/jpet.105.100362_bib34","doi-asserted-by":"crossref","unstructured":"Rauch F, Travers R, Parfitt AM, and Glorieux FH (2000) Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone (NY) 26: 581\u2013589.","DOI":"10.1016\/S8756-3282(00)00269-6"},{"key":"10.1124\/jpet.105.100362_bib35","doi-asserted-by":"crossref","unstructured":"Roodman GD (1999) Cell biology of the osteoclast. Exp Hematol 27: 1229\u20131241.","DOI":"10.1016\/S0301-472X(99)00061-2"},{"key":"10.1124\/jpet.105.100362_bib36","doi-asserted-by":"crossref","unstructured":"Takyanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, et al. (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-\u03b3. Nature (Lond) 408: 600\u2013605.","DOI":"10.1038\/35046102"},{"key":"10.1124\/jpet.105.100362_bib37","doi-asserted-by":"crossref","unstructured":"Wada Y, Shimada K, Sugimoto K, Kimura T, and Ushiyama S (2006) Novel p38 mitogen-activated protein kinase inhibitor R-130823 protects cartilage by down-regulating matrix metalloproteinase-1,-13 and prostaglandin E2 production in human chondrocytes. Int Immunopharmacol 6: 144\u2013155.","DOI":"10.1016\/j.intimp.2005.07.009"},{"key":"10.1124\/jpet.105.100362_bib38","doi-asserted-by":"crossref","unstructured":"Weinstein RS, Nicholas RW, and Manolagas SC (2000) Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab 85: 2907\u20132912.","DOI":"10.1210\/jc.85.8.2907"},{"key":"10.1124\/jpet.105.100362_bib39","doi-asserted-by":"crossref","unstructured":"Wolfe F and Strand V (2001) Radiography of rheumatoid arthritis in the time of increasing drug effectiveness. Curr Rheumatol Rep 3: 46\u201352.","DOI":"10.1007\/s11926-001-0050-1"},{"key":"10.1124\/jpet.105.100362_bib40","doi-asserted-by":"crossref","unstructured":"Xing L, Bushnell TP, Carlson L, Tai Z, Tondravi M, Siebenlist U, Young F, and Boyce BF (2002) NF-\u03baB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. J Bone Miner Res 17: 1200\u20131210.","DOI":"10.1359\/jbmr.2002.17.7.1200"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524327053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524327053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.105.100362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:52:51Z","timestamp":1740001971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524327053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0022356524327053"],"URL":"https:\/\/doi.org\/10.1124\/jpet.105.100362","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of p38 Mitogen-Activated Protein Kinase Prevents Inflammatory Bone Destruction","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.105.100362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}